Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Cell Reports|May 16, 2025
Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activationJoana R Costa, Yang Li, Nurkaiyisah Zaal Anuar, et al.
Oncotarget|February 22, 2018
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology groupRisa Niemas-Teshiba, Ryosuke Matsuno, Larry L Wang, et al.
Plos One|July 7, 2012
NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive nichesWenxue Ma, Alejandro Gutierrez, Daniel J Goff, et al.
Cancer Medicine|July 16, 2019
Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Takeshi Inukai, Keiko Kagami, et al.
The Journal of Clinical Investigation|January 10, 2014
Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemiaAlejandro Gutierrez, Li Pan, Richard W J Groen, et al.
Frontiers in Immunology|August 8, 2025
CREB regulates Foxp3+ST-2+ TREGS with enhanced IL-10 productionSudheendra Hebbar Subramanyam, Judit Turyne Hriczko, Saskia Schulz, et al.
Scientific Reports|March 5, 2021
Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)Timothy I Shaw, Li Dong, Liqing Tian, et al.
Blood|August 6, 2005
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemiaRoss L Levine, Marc Loriaux, Brian J P Huntly, et al.
Blood|March 9, 2017
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Michael Magnussen, Theresa E León, et al.
Pediatric Blood & Cancer|June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology CommitteeRie Suganuma, Larry L Wang, Hideki Sano, et al.
Pageof 23